Evidence map›Paper›PMID 29103401›Full record

ArticleEpidemiology and infection2017

Hepatitis E virus (HEV): seroprevalence and HEV RNA detection in subjects attending a sexually transmitted infection clinic in Brussels, Belgium.

N Dauby, V Suin, M Jacques, M Abady, S VAN DEN Wijngaert, M Delforge, S DE Wit, A Libois

Open access · bronzeAbstract read
In one paragraph

Article in Epidemiology and infection, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.7field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 9 citations in OpenAlex.

  1. Trial
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

N DaubyDepartment of Infectious Diseases,CHU Saint-Pierre, Université Libre de Bruxelles (ULB),Brussels,Belgium.ORCID 0000-0002-7697-6849
V SuinNational Reference Center for Viral Hepatitis, Communicable and Infectious Diseases, Scientific Institute of Public Health (WIV-ISP),Brussels,Belgium.
M JacquesNational Reference Center for Viral Hepatitis, Communicable and Infectious Diseases, Scientific Institute of Public Health (WIV-ISP),Brussels,Belgium.
M AbadyNational Reference Center for Viral Hepatitis, Communicable and Infectious Diseases, Scientific Institute of Public Health (WIV-ISP),Brussels,Belgium.
S VAN DEN WijngaertLHUB-ULB,Brussels,Belgium.
M DelforgeDepartment of Infectious Diseases,CHU Saint-Pierre, Université Libre de Bruxelles (ULB),Brussels,Belgium.
S DE WitDepartment of Infectious Diseases,CHU Saint-Pierre, Université Libre de Bruxelles (ULB),Brussels,Belgium.
A LiboisDepartment of Infectious Diseases,CHU Saint-Pierre, Université Libre de Bruxelles (ULB),Brussels,Belgium.
Université Libre de Bruxelles · BEInstitut Scientifique de Santé Publique · BEEuropean Biodiesel Board · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Men who have sex with men (MSM) have an increased incidence of pathogens transmitted by the oro-fecal route. Hepatitis E virus (HEV) is an emerging cause of acute hepatitis and fecal shedding is observed during primary infection. We investigated whether MSM are at increased risk of HEV infection. Subjects who attended a sexually transmitted infection clinic in Brussels and had an HIV test performed between 1 June 2014 and 15 January 2016 were identified. A total of 576 samples were retrospectively screened for both total HEV IgG and HEV RNA. Samples positive for IgG were tested for IgM. MSM proportion was 31·1% (179/576). Overall HEV IgG prevalence was 9·03% (52/576) and was identical in MSM and heterosexual subjects. Among the IgG positive samples, 2/52 (3·84%) samples (both women) were positive for anti-HEV IgM. No sample was positive for HEV RNA. Age over 35 was the only risk factor significantly associated with HEV seropositivity (OR 2·07; 95% CI 1·16-3·67). In conclusion, MSM were not found to have an increased prevalence of HEV as previously reported in other European countries suggesting distinct dynamics of HEV infection in this group across Europe and increased age was associated with a higher risk of seropositivity.

Indexed as

AdultBelgiumCommunity Health CentersFemaleHepatitis AntibodiesHepatitis EHepatitis E virusHumansMaleRetrospective StudiesRNA, ViralSeroepidemiologic StudiesSexually Transmitted DiseasesHepatitis AntibodiesRNA, ViralepidemiologyHepatitis Eserologyviral hepatitis

Identifiers

PMID29103401
PMCPMC9148740
OpenAlexW2767874483

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.